The U.S. Food and Drug Administration has approved a second blood test to improve the detection of Alzheimer’s disease. The ...

The test is intended for adults 55 and older in the United States who are showing signs or symptoms of cognitive decline.

The FDA has cleared Roche's Elecsys pTau181 test, a blood-based biomarker test for Alzheimer's disease, allowing for earlier ...

Research published in the journal BMJ Open in May found that an annual blood test for cancer could lead to 49 per cent fewer ...

This work is the first to introduce a practical framework for addressing one of the biggest obstacles to healthcare AI adoption: clinician trust. It emphasizes transparency and adaptability as ...

An important scientific study published in The Lancet shows the strong public health impact of deploying molecular diagnostics closer to the people.

When the dreaded malfunction indicator light turns on, it’s not the end of the world. Here’s how to cope with an MIL!

Wyatt Technology's DynaPro Plate Reader 4 integrates advanced light scattering techniques, optimizing workflows in ...

Researchers from the University of East Anglia and biotechnology company Oxford Biodynamics have developed a new blood test for diagnosing ME/CFS with 96% accuracy.

Can your bathroom double as a lab? At-home testing is reshaping how we learn about our bodies — and raising new questions.

Near-death experiences can bring peace and heartbreak. A UVA study shows how NDEs reshape lives, strain families, and what ...

Postpartum depression affects some one in eight women in the United States. It typically occurs in the first weeks after ...